Another overexpressed factor on the tumor-associated vasculature that has been implicated in TILs exclusion is Fas ligand (FasL), produced by murine and human tumors, like ovarian, colon, prostate, breast, bladder, and renal cancer (223). Here, FASLG is linked to renal carcinoma.